Your search returned 3 results.

Results
	1.	Circulating tumor cells predict progression free survival and overall survival in patients with relapsed/recurrent advanced ovarian cancer. [electronic resource] by Poveda, Andres Kaye, Stanley B McCormack, Robert Wang, Songbai Parekh, Trilok Ricci, Deborah Lebedinsky, Claudia A Tercero, Juan Carlos Zintl, Patrik Monk, Bradley J Producer: 20110926 In: Gynecologic oncology vol. 122 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Phase I and pharmacokinetic study of trabectedin as a 1- or 3-hour infusion weekly in patients with advanced solid malignancies. [electronic resource] by Forouzesh, Bahram Hidalgo, Manuel Chu, Quincy Mita, Alain Mita, Monica Schwartz, Garry Jimeno, José Gómez, Javier Alfaro, Vicente Lebedinsky, Claudia Zintl, Patrik Rowinsky, Eric K Producer: 20090803 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 15 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Trabectedin as single agent in relapsed advanced ovarian cancer: results from a retrospective pooled analysis of three phase II trials. [electronic resource] by del Campo, José María Sessa, Cristiana Krasner, Carolyn N Vermorken, Jan B Colombo, Nicoletta Kaye, Stan Gore, Martin Zintl, Patrik Gómez, Javier Parekh, Trilok Park, Youn Choi McMeekin, Scott Producer: 20130917 In: Medical oncology (Northwood, London, England) vol. 30 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)